Clinical management of women with genomic BRCA1 and BRCA2 mutations* Jenny ChangRichard M. Elledge OriginalPaper Pages: 101 - 113
Expression of E2F-1 and E2F-4 is reduced in primary and metastatic breast carcinomas* Gay Hui HoJacqueline E. CalvanoKimberly J. Van Zee OriginalPaper Pages: 115 - 122
Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use? S. Kasimir-BauerC. OberhoffS. Seeber OriginalPaper Pages: 123 - 132
Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992–1995 Lisa C. RichardsonJane SchulmanRalph J. Coates OriginalPaper Pages: 133 - 142
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease Carla FiorentinoAlfredo BerrutiLuigi Dogliotti OriginalPaper Pages: 143 - 151
Chemoprevention of DMBA-induced mammary cancer in rats by dietary soy Daniela GalloSabrina GiacomelliGiovanni Scambia OriginalPaper Pages: 153 - 164
Adherence to recommendations for clinical follow-up after benign breast biopsy Michael A. AndrykowskiJanet S. CarpenterPatrick McGrath OriginalPaper Pages: 165 - 178